Vor Biopharma Inc.

Healthcare

NASDAQ:VOR · NASDAQ Global Select

Market Cap $102.95M Beta 1.73 P/E (TTM) -0.0

$14.49 -2.26%

-$0.34 today

52W Low $4.28High $65.80

Vol 1.66M · Avg 1.07M

EPS (TTM) -$2,053.13Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+149.83%

Period High

$53.40

Period Low

$5.80

Latest

$14.49

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Forte Biosciences, Inc.

NASDAQ:FBRX

$248.62M

Fate Therapeutics, Inc.

NASDAQ:FATE

$233.12M

Nkarta, Inc.

NASDAQ:NKTX

$194.96M

Alector, Inc.

NASDAQ:ALEC

$181.53M

Spero Therapeutics, Inc.

NASDAQ:SPRO

$127.38M

PepGen Inc.

NASDAQ:PEPG

$123.81M

Anixa Biosciences, Inc.

NASDAQ:ANIX

$94.41M

Seres Therapeutics, Inc.

NASDAQ:MCRB

$62.75M

Actuate Therapeutics Inc

NASDAQ:ACTU

$49.73M

Applied Therapeutics, Inc.

APLT

$14.86M

What is the latest VOR filing?

The latest filing shown is 4 dated Jun 12, 2026.

How many recent filings does VOR have?

Intrinsic Alpha currently shows 20 recent filings for VOR.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.